PRESS RELEASE published on 09/19/2023 at 07:11, 1 year 2 months ago Heidelberg Pharma AG: Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101
PRESS RELEASE published on 08/08/2023 at 07:46, 1 year 3 months ago Heidelberg Pharma AG: Heidelberg Pharma’s Partner Takeda Reached Development Milestone
PRESS RELEASE published on 07/13/2023 at 07:04, 1 year 4 months ago Heidelberg Pharma Reports on First Half-Year 2023 and the Course of Business
PRESS RELEASE published on 06/29/2023 at 09:45, 1 year 4 months ago EQS-Adhoc: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics
PRESS RELEASE published on 05/25/2023 at 15:17, 1 year 5 months ago Heidelberg Pharma reports on the results of the Annual General Meeting 2023
PRESS RELEASE published on 05/05/2023 at 12:25, 1 year 6 months ago Heidelberg Pharma appoints Chief Financial Officer
PRESS RELEASE published on 04/13/2023 at 07:10, 1 year 7 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
PRESS RELEASE published on 04/04/2023 at 10:12, 1 year 7 months ago Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
PRESS RELEASE published on 03/24/2023 at 07:11, 1 year 7 months ago Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
Published on 11/21/2024 at 14:00, 18 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 18 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 18 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 48 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 43 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 3 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 20 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 58 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 33 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 33 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
